Pakistan and Egypt Deepen Cooperation in Healthcare and Pharmaceuticals

Pakistan and Egypt have reaffirmed their commitment to strengthening bilateral cooperation in the health sector, with a focus on pharmaceuticals, medical capacity building, and collaboration at international health forums.

The development was announced following a meeting between Egypt’s Ambassador to Pakistan and Federal Health Minister Syed Mustafa Kamal. Both sides reviewed progress in existing collaborations and discussed new opportunities to expand healthcare initiatives.

Minister Kamal emphasized that Pakistan and Egypt share longstanding brotherly relations rooted in mutual respect and shared values. He noted that healthcare has emerged as a vital pillar of bilateral ties, reflecting both nations’ commitment to improving public health outcomes.

The Egyptian ambassador highlighted the importance of health collaboration as an enduring dimension of Pakistan-Egypt relations. He praised the close coordination between the two countries at international platforms, particularly the World Health Organization (WHO).

During the meeting, Minister Kamal lauded Egypt’s active role at the 159th session of the WHO, where it presented resolutions on precision medicine and fatty liver disease. Pakistan supported both initiatives, recognizing their alignment with global health priorities.

Egypt’s success in combating hepatitis C was also acknowledged as a model for Pakistan’s own disease elimination efforts. The minister appreciated Egypt’s cooperation in providing medicines for hepatitis prevention and treatment, underscoring the shared commitment to tackling liver-related diseases.

Both sides agreed to further strengthen collaboration in pharmaceuticals and healthcare system development. The partnership aims to deliver mutual benefits for the people of Pakistan and Egypt, while contributing to broader global health goals.

This renewed cooperation reflects a forward-looking strategy, positioning Pakistan and Egypt as active partners in advancing medical innovation, disease prevention, and international health diplomacy.